{
  "docId": "019de073-b41a-7298-b152-a88168c594ee",
  "docSlug": "fcd1785019fd61535487d85f646654d9",
  "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 39 slides",
  "authorId": "enochian-biosciences",
  "authorName": "Enochian BioSciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7744917,
  "pageNumber": 7,
  "pageCount": 39,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "business_model",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The diagram uses a branching logic to show how core pipelines lead to multiple indications/products, which then feed into a value-maximization arrow.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de073-b41a-7298-b152-a88168c594ee/7",
  "deckHref": "/decks/019de073-b41a-7298-b152-a88168c594ee",
  "deckJsonHref": "/decks/019de073-b41a-7298-b152-a88168c594ee.json",
  "deckAnchorHref": "/decks/019de073-b41a-7298-b152-a88168c594ee#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.9,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "callout",
      "text": "Combining novel cell, gene and immunotherapy to build a diverse pipeline across and within diseases to allow for better business decisions to sell, sub-license, partner or manufacture and maximize patient impact and shareholder value.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd6ea3c3-3eeb-4335-94ea-6b9db8d9b990",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.9,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "diagram",
      "text": "Oncology and Infectious Disease pipelines branching into specific indications and products, feeding into a value-maximization arrow.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0431b54-8b3b-4d5b-824f-3709a7bc8c73",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "STRATEGY: LEVERAGE INNOVATIVE PLATFORMS TO CREATE \"MULTIPLE SHOTS ON GOAL\" & NEW INTELLECTUAL PROPERTY",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a9de8eea-90d2-47bf-b978-03f43b91ef83",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Three-Act Structure",
      "slug": "three-act-structure",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "ca522354-35a7-4806-886a-398469001f28",
      "evidence": "The slide presents a strategy to leverage innovative platforms, which can be seen as an act in a three-act structure.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "business-model",
      "slug": null,
      "matchId": "4044f80c-667f-4f93-8ba4-92447d7ced25",
      "evidence": "The slide describes how the company creates value through pipeline diversification and multiple commercialization paths.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}